Asarfi Hospital [ASARFI] vs Shalby [SHALBY] Detailed Stock Comparison
Asarfi Hospital
BSE
Loading...
Shalby
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Asarfi Hospital wins in 12 metrics, Shalby wins in 5 metrics, with 0 ties. Asarfi Hospital appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Asarfi Hospital | Shalby | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 24.44 | 1,126.78 | Asarfi Hospital |
| Price-to-Book Ratio | 3.06 | 1.99 | Shalby |
| Debt-to-Equity Ratio | 55.65 | 9.69 | Shalby |
| PEG Ratio | N/A | 21.58 | N/A |
| EV/EBITDA | 11.56 | 13.36 | Asarfi Hospital |
| Profit Margin (TTM) | 8.83% | 0.57% | Asarfi Hospital |
| Operating Margin (TTM) | 14.60% | 1.74% | Asarfi Hospital |
| EBITDA Margin (TTM) | 14.60% | 1.74% | Asarfi Hospital |
| Return on Equity | 14.56% | 0.19% | Asarfi Hospital |
| Return on Assets (TTM) | 5.28% | 2.52% | Asarfi Hospital |
| Free Cash Flow (TTM) | $-161.37M | $-757.89M | Asarfi Hospital |
| Dividend Yield | N/A | 0.65% | N/A |
| 1-Year Return | 103.60% | -23.68% | Asarfi Hospital |
| Price-to-Sales Ratio (TTM) | 1.97 | 2.00 | Asarfi Hospital |
| Enterprise Value | $3.03B | $17.72B | Shalby |
| EV/Revenue Ratio | 2.32 | 1.63 | Shalby |
| Gross Profit Margin (TTM) | 77.89% | 37.50% | Asarfi Hospital |
| Revenue per Share (TTM) | $66 | $112 | Shalby |
| Earnings per Share (Diluted) | $5.37 | $0.18 | Asarfi Hospital |
| Beta (Stock Volatility) | N/A | 0.46 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Asarfi Hospital vs Shalby Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Asarfi Hospital | -1.15% | -1.52% | -11.56% | 33.62% | 44.20% | 30.04% |
| Shalby | 1.56% | -2.37% | 11.32% | 7.77% | -1.01% | -12.25% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Asarfi Hospital | 103.60% | 15.56% | 15.56% | 15.56% | 15.56% | 15.56% |
| Shalby | -23.68% | 59.89% | 132.06% | -15.35% | -15.35% | -15.35% |
Performance & Financial Health Analysis: Asarfi Hospital vs Shalby
| Metric | ASARFI | SHALBY |
|---|---|---|
| Market Information | ||
| Market Cap | ₹2.58B | ₹21.76B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 10,500 | 201,770 |
| 90 Day Avg. Volume | 20,133 | 320,175 |
| Last Close | ₹128.50 | ₹205.99 |
| 52 Week Range | ₹52.84 - ₹150.00 | ₹177.25 - ₹297.90 |
| % from 52W High | -14.33% | -30.85% |
| All-Time High | ₹150.00 (Jul 11, 2025) | ₹339.50 (Jan 22, 2024) |
| % from All-Time High | -14.33% | -39.33% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.38% | 0.09% |
| Quarterly Earnings Growth | 0.45% | 0.11% |
| Financial Health | ||
| Profit Margin (TTM) | 0.09% | 0.01% |
| Operating Margin (TTM) | 0.15% | 0.02% |
| Return on Equity (TTM) | 0.15% | 0.00% |
| Debt to Equity (MRQ) | 55.65 | 9.69 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹42.85 | ₹101.79 |
| Cash per Share (MRQ) | ₹0.85 | ₹32.80 |
| Operating Cash Flow (TTM) | ₹26.36M | ₹-43,430,000 |
| Levered Free Cash Flow (TTM) | ₹43.26M | ₹-887,275,008 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.65% |
| Last 12-Month Dividend | N/A | ₹1.20 |
Valuation & Enterprise Metrics Analysis: Asarfi Hospital vs Shalby
| Metric | ASARFI | SHALBY |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 24.44 | 1,126.78 |
| Forward P/E | N/A | 21.58 |
| PEG Ratio | N/A | 21.58 |
| Price to Sales (TTM) | 1.97 | 2.00 |
| Price to Book (MRQ) | 3.06 | 1.99 |
| Market Capitalization | ||
| Market Capitalization | ₹2.58B | ₹21.76B |
| Enterprise Value | ₹3.03B | ₹17.72B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.32 | 1.63 |
| Enterprise to EBITDA | 11.56 | 13.36 |
| Risk & Other Metrics | ||
| Beta | N/A | 0.46 |
| Book Value per Share (MRQ) | ₹42.85 | ₹101.79 |
Financial Statements Comparison: Asarfi Hospital vs Shalby
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ASARFI | SHALBY |
|---|---|---|
| Revenue/Sales | ₹338.92M | ₹2.65B |
| Cost of Goods Sold | ₹74.95M | ₹1.66B |
| Gross Profit | ₹263.97M | ₹993.23M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹18.23M | ₹46.11M |
| EBITDA | ₹98.93M | ₹261.61M |
| Pre-Tax Income | ₹52.95M | ₹-7.38M |
| Income Tax | ₹17.06M | ₹114.50M |
| Net Income (Profit) | ₹35.89M | ₹-121.88M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ASARFI | SHALBY |
|---|---|---|
| Cash & Equivalents | ₹14.26M | ₹347.85M |
| Total Current Assets | ₹584.84M | ₹6.58B |
| Total Current Liabilities | ₹410.39M | ₹4.55B |
| Long-Term Debt | ₹338.29M | ₹1.75B |
| Total Shareholders Equity | ₹809.83M | ₹9.95B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹1.02B | ₹8.88B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ASARFI | SHALBY |
|---|---|---|
| Operating Cash Flow | ₹-93.10M | ₹433.19M |
| Capital Expenditures | ₹-38.61M | ₹-563.59M |
| Free Cash Flow | ₹-106.81M | ₹-66.61M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ASARFI | SHALBY |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 10,500 | 201,770 |
| Average Daily Volume (90 Day) | 20,133 | 320,175 |
| Shares Outstanding | 19.68M | 107.27M |
| Float Shares | 5.65M | 24.09M |
| % Held by Insiders | 0.70% | 0.67% |
| % Held by Institutions | 0.00% | 0.00% |
Dividend Analysis & Yield Comparison: Asarfi Hospital vs Shalby
| Metric | ASARFI | SHALBY |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹1.20 |
| Last 12-Month Dividend Yield | N/A | 0.65% |
| 3-Year Avg Annual Dividend | N/A | ₹1.08 |
| 3-Year Avg Dividend Yield | N/A | 0.55% |
| 3-Year Total Dividends | N/A | ₹3.23 |
| Ex-Dividend Date | N/A | Sep 19, 2024 |